Riva Kovjazin

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

Rachel Eren, Dorit Landstein, Dov Terkieltaub et al. · Journal of Virology · 2006 · 101 citations · Full text

Histocompatibility, Prevent Hcv Reinfection, Complement Fixation +22

Ferrocene‐induced lymphocyte activation and antitumor activity is mediated by redox‐sensitive signaling

Riva Kovjazin, Tova Eldar, Miriam Patya et al. · The FASEB Journal · 2003 · 61 citations

Antitumor Activity, Immunotoxicology, Iron Metabolism +18

Phase I/<scp>II</scp> study exploring ImMucin, a pan‐major histocompatibility complex, anti‐<scp>MUC</scp>1 signal peptide vaccine, in multiple myeloma patients

Lior Carmon, Irit Avivi, Riva Kovjazin et al. · British Journal of Haematology · 2014 · 56 citations · Full text

Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development

Riva Kovjazin, Ilan Volovitz, Yair Daon et al. · Molecular Immunology · 2011 · 49 citations

Vaccination, Vaccine Development, Autoimmune Disease +12

ImMucin: A novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors

Riva Kovjazin, Ilan Volovitz, Yulia Kundel et al. · Vaccine · 2011 · 42 citations

Novel Therapeutic Vaccine, Mucosal Vaccination, Tumor Immunology +9